drugset / Trial / NCT01897142
A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers
RandomizedDouble-blindBasic science
Summary
The purpose of this study is to determine what the study drug does to the body, what the body does to the study drug, and if the study drug is safe and well tolerated when given to adult healthy volunteers.
Timeline
- Start
- 2013-09
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-05230907 | Unknown | 0.1 ug/kg | Intravenous |
| Subject | PF-05230907 | Unknown | 0.3 ug/kg | Intravenous |
| Subject | PF-05230907 | Unknown | 1 ug/kg | Intravenous |
| Subject | PF-05230907 | Unknown | 2 ug/kg | Intravenous |
| Subject | PF-05230907 | Unknown | 3 ug/kg | Intravenous |
| Subject | PF-05230907 | Unknown | 5 ug/kg | Intravenous |
Indications
No indication recorded.